Søgning
Søgning på udtrykket 'hiv' giver 83 resultater
Dokumenter [21]
Sider [11]
Kalender [2]
Nyt fra tidsskrifterne [+20]
Aktuelle smitsomme sygdomme [+20]
Udarbejdet af arbejdsgruppe fra Dansk Selskab for Infektionsmedicin og Dansk Fertilitetsselskab.
Udarbejdet af arbejdsgruppe under Dansk Selskab for Infektionsmedicin
Udarbejdet af DSI's arbejdsgruppe vedrørende antiretroviral terapi
Om håndtering og opfølgning for at minimere risiko for smitte med bl.a. HIV, HBV og HCV.
[…] medicin i form af f.eks TNF-α hæmmere eller andre immunsupprimerende biologiske lægemidler, hvor der er øget risiko for tuberkulosereaktivering. Guideline dækker ikke børn, personer med medfødt immundefekt, HIV positive, patienter i dialyse, patienter med dysreguleret diabetes, silicose, erhvervede immundefekter eller patienter i konventionel kortvarig kemoterapi. Denne guideline omhandler ikke klassisk smitteopsporing blandt tuberkuloseeksponerede eller udredning på mistanke om aktiv […]
[…] (BMSL) til patienter i forhold til risiko for tuberkulose (TB), Humant Papillom Virus (HPV), Hepatitis B og C (HBV og HCV), Varicella Zoster Virus (VZV), Herpes Simplex Virus (HSV), Cytomegalovirus (CMV), Epstein Barr Virus (EBV) og Humant Immundefekt Virus (HIV) og øvrige infektioner. Vejledningen er udarbejdet af repræsentanter fra Dansk Selskab for Gastroenterologi og Hepatologi (DSGH), Dansk Reumatologisk Selskab (DRS), Dansk Dermatologisk Selskab (DDS) og Dansk Selskab for Infektionsmedicin […]
Retningslinje for udlevering af Pre-exposure profylakse (PrEP) mod HIV, version 1. maj 2025.
Arrangeret af Yngre Infektionsmedicinere
Henvendelse til Danske regioner
Bl.a. om HIV, hepatitis, resistente bakterier og immundefekt
Bl.a. om HIV, hepatitis, influenza og CNS infektioner
Bl.a. om HIV, hepatitis, cystisk fibrose og nye guidelines
Correspondence regarding 'Use of statins and risk of AIDS-defining and non-AIDS-defining malignancies among HIV-1 infected patients on antiretroviral therapy'
DANHIV blev oprettet som en regional klinisk kvalitetsdatabase i RegionH i sommeren 2015. Imidlertid har projektet fungeret som Det Danske HIV Kohorte Studie (DHK) siden 1998. DHK har fungeret som en kombineret kvalitetsdatabase og forskningsdatabase. Data i DHK går tilbage til 1. januar 1995, hvorfor vi allerede nu kan vise udviklingen over en lang årrække for de forskellige indikatorer.
Bl.a. om sygdom efter udlandsrejse, resistens og kroniske virale infektioner
Forfattet af DSI's arbejdsgruppe vedrørende antiviral behandling
Bilag til Retningslinjer for screening og profylakse før behandling med biologiske lægemidler (2023)
[…] for kontrolopfølgning og udleveringspraksis Anbefalinger i forhold til medicinen Ændringslog PrEP målgruppe Målgruppen for den forebyggende behandling er personer, der ud fra en række objektive kriterier er i højrisiko for at blive smittet med HIV. Det anbefales, at PrEP gives til personer, der opfylder alle af nedenstående kriterier: Personen er HIV-negativ. Personen tilhører gruppen af mænd, der har sex med mænd, eller gruppen af transkvinder eller transmænd, der har sex med mænd, og opfylder mindst 1 […]
[…] At kursisten skal opnå en forståelse af HIV-infektionen herunder viden om dens epidemiologi, patogenese, patofysiologi, diagnose, forebyggelse, behandlingsmuligheder og prognose samt viden om diagnostik og behandlingen af AIDS-definerende sygdomme og de hyppigste sexuelt overførte sygdomme. Tid og sted Hvidovre Hospital. Lokale 10 i undervisningsbygningen Delkursusledere Ann-Brit Eg Hansen og Ole Kirk Program Mandag 3. oktober 10:00-10:15 Velkomst og introduktion (Ann-Brit Eg Hansen og Ole Kirk) […]
[…] terrorisme. Specialet er karakteriseret ved et sygdomspanorama hvor sygdommenes prævalens såvel som incidens ændres hurtigt på lokalt og globalt plan. Over de seneste tyve år har specialet udviklet sig til at håndtere behandlingen af HIV og AIDS. I de seneste år er nye alvorlige infektionssygdomme som SARS, fugleinfluenza, West Nile virus, Hanta virus, Nipah virus, og Hendra virus tilkommet. Alvorlige sygdomme som hæmoragisk viral feber forårsaget af Ebola, Lassa, Dengue, Crimean-Congo, Rift Valley […]
[…] af seksuelt overførte sygdomme Frederik Neess Engsig (tovholder), Birgit Thorup Røge, Gitte Kronborg, Lars Nørregaard Nielsen, Carsten Schade Larsen, Steffen Leth, Lone Hagens Mygind Pre-exposure profylakse mod HIV (PrEP) Gastrointestinale infektioner Karina Frahm Kirk (tovholder), Morten Helms, Merete Storgaard, Janne Fuglsang Hansen, Mike Zangenberg Clostridioides difficile infektion Hepatitis Akut viral hepatitis Carsten Shade Larsen (tovholder) og Nina Weis Hepatitis A Hepatitis elimination i […]
[…] for næste kursus 2026 Sted Odense Universitetshospital Delkursusledelse Lone Mygind, Micha Jepsen og Belinda Mössner Tidligere kurser 4. og 5. december 2023 3. og 4. december 2020 HIV-infektion Næste kursus 30. og 31. oktober 2025 (2 dage) Sted Aarhus Universitetshospital (AUH) Delkursusledelse Ole Schmeltz Søgaard og Lene Ryom Nielsen Program Afventer […]
[…] terrorisme. Specialet er karakteriseret ved et sygdomspanorama hvor sygdommenes prævalens såvel som incidens ændres hurtigt på lokalt og globalt plan. Over de seneste tyve år har specialet udviklet sig til at håndtere behandlingen af HIV og AIDS. I de seneste år er nye alvorlige infektionssygdomme som SARS, fugleinfluenza, West Nile virus, Hanta virus, Nipah virus, og Hendra virus tilkommet. Alvorlige sygdomme som hæmoragisk viral feber forårsaget af Ebola, Lassa, Dengue, Crimean-Congo, Rift Valley […]
[…] og måling af alfaføtoprotein Indikation for behandling varierer for patienter med HBV-infektion afhængig af fibrosegrad, HBV DNA-værdi og ALAT-værdi. For grupper af patienter med kronisk hepatitis B og samtidig HDV-infektion, HIV-infektion, familiær anamnese for HCC eller graviditet er indikation for behandling baseret på andre årsager, uafhængig af ovenstående Oversigt Årsag Hepatitis B skyldes infektion med hepatitis B virus Prævalens i Danmark Ca. 14.500 […]
[…] af akut bakteriel meningitis hos voksne Afgrænsning Denne vejledning omhandler diagnostik og behandling af samfundserhvervet akut bakteriel meningitis hos voksne. For rekommandationer vedrørende encefalitis eller viral meningitis henvises til guidelines herfor på infmed.dk/. Der er ikke foretaget en gradering af evidensniveau, da der på nær for anvendelse af antibiotika og steroid ikke foreligger solid evidens for store dele af feltet. Genveje Afgrænsning Genveje […]
[…] af akut bakteriel meningitis hos voksne Afgrænsning Denne vejledning omhandler diagnostik og behandling af samfundserhvervet akut bakteriel meningitis hos voksne. For rekommandationer vedrørende encefalitis eller viral meningitis henvises til guidelines herfor på infmed.dk/. Der er ikke foretaget en gradering af evidensniveau, da der på nær for anvendelse af antibiotika og steroid ikke foreligger solid evidens for store dele af feltet. Genveje Afgrænsning Genveje […]
[…] summerer på en rimelig afbalanceret måde den globale kontrovers, som 2013 var præget af, om hvorvidt ART skal benyttes som forebyggende middel, som led i en individuel-baseret eller en folkesundsbaseret strategi for at reducere smittespredning af HIV. De udfordringer som den vestlige verden, trods udbredt og gratis behandlingstilbud, har med at få styr på smittespredning blandt fx mænd-der-har-sex-med-mænd viser, at det - der intuitivt synes ligefor - ikke nødvendigvis virker når det kommer til […]
[…] Henrik Nielsen kommenterer: Trods indiskutable fremskridt i den farmakologiske behandling af HIV/AIDS er der fortsat områder med plads til forbedring. Blandt patienter i kronisk behandling er HAND (HIV-associated neurocognitive disorder) et af disse eksempler. Det har været debatteret om forskelle i antiretrovirale lægemidlers penetrans over blod/hjerne barrieren har betydning for HAND og for AIDS-definerende opportunistisk infektion i hjernen. Der er ingen tvivl om at […]
[…] Jens Lundgren kommenterer: I 2014 var verden optaget af Ebola udbruddet i Vest Afrika – et udbrud der blev erkendt hurtigt (om end den internationale assistance lod vente på sig). Vedlagte artikel belyser detaljeret hvorledes HIV pandemien startede i 1920’erne og hvor det jo som bekendt tog over 60 år af finde ud at der overhovedet var et problem. Synes artiklen er godt skrevet og giver et indblik i Afrika for 90 års siden og de ingredienser der skulle til for at […]
[…] Lars Østergaard kommenterer: Jeg vil gerne anbefale vedlagte artikel som julemånedslæsning. Grundene er som følger: 1) Det vises for første gang, at et medikament kan reaktivere latent HIV-virus under samtidig HAART-behandling i en grad, så virus kan påvises i perifert blod. 2) Der er (omend videnskaligt svage) indicier på, at HIV-reservoir kan reduceres hos nogle patienter, og at effekten af det innate immunforsvar er af betydning herfor. 3) Det er den første originalartikel trykt i den […]
[…] Jens Lundgren kommenterer: I 2015 nåede WHO sit mål om at få 15 million på behandling. START studiet afklarede også at alle HIV+ personer har gavn af at starte på HIV behandling.Der er fortsat mere end 20 millioner der endnu ikke er startet. Hovedparten bor i ressource svage lande hvor adgang til monitorering af HIV mængden er begrænset og behandlingsskift pga behandlingssvigt er derfor primært drevet af klinik og CD4 tals måling.Omkostning ifm nyttevirkning er central i at forbedre […]
[…] at dolutegravir, især når det kombineres med TAF fremfor tenofovir DF, forårsager markant vægtøgning. Især hos kvinder med mørk hudfarve.Artiklen gør indtryk af en række grunde: Da dolutegravir blev markedsført havde det profilen som det eneste HIV præparat uden bivirkninger. Læring: der er ingen medicinske præparater der ikke har nogle bivirkninger, og typen af bivirkninger kan ikke altid forudsiges udfra markedsføringsstudier (fase I-III). Dette faktum er universelt og set for praktisk taget alle HIV […]
Professor Jens Lundgren kommenterer: Første lægemiddel mod SARS-CoV-2 udviklet fra ”bunden” – bruger et gammel trick fra HIV medicinen (ritonavir) for at holde plasma koncentrationerne oppe. Læringen er, at det tager tid at lave nye lægemidler helt fra bunden, men det er noget nær en verdensrekord så hurtigt som det skete under pandemien – både hvad angår vacciner (hvor det tog < 1 år fra design ex vivo til markedsføring), men altså ca 2 år for lægemidler som dette.
[…] Lars Østergaard kommenterer: Indimellem kommer der studier, som er så overbevisende, at det sætter en ny behandlingsstandard. Det kan f.eks. være Lundgrens studie af, hvornår man kan holde op med at give pneumocyste-profylakse til HIV-smittede eller de Gans studiet, der ændrede fik indført dexamethason i retningslinjerne for purulent meningitis. Her er formentlig et nyt studie, der kommer til at få indflydelse på standardbehandlingen af patienter med svær pneumoni. Læs en gang - og døm selv - jeg […]
[…] Troels Lillebæk kommenterer: Interessant systematisk review i AIDS om udbytte af screening for tuberkulose infektion (TBI) blandt personer, der lever med HIV (PLHIV) i tuberkulose lav-incidens lande (som Danmark) . Inddraget i alt 51 undersøgelser med 65.930 PLHIV hvoraf 12 % havde en positiv LTBI-test, som var stærkt relateret til oprindelsesland og eksponering for TB ). Forfatterne beretter at 20 TBI-positive personer skulle behandles for at forhindre ét tilfælde af TB, og at antallet, der var […]
3. september 2026, Online
Nyt fra tidsskrifterne [+20]
Der er mere end 20 resultater, måske du vil se flere resultater her?
PLoS One Infectious Diseases
11. november 2025
[…] Thanh Ha-Lan Hoang, Gloria Guevara Alvarez, Louise Adermark, Nawi Ng, Trang Nguyen, Nam Nguyen, Donna Shelley Background People living with HIV (PLWH) who smoke face significant health risks from tobacco use, which dual use of cigarettes and waterpipes may exacerbate due to increased nicotine exposure and dependency. This study examined the sociodemographic, behavioral, psychosocial and health-related factors associated with dual smoking among PLWH receiving care at HIV clinics in Hanoi, Vietnam. […]
International Journal of Infectious Diseases
11. november 2025
[…] persons living with HIV (PLWH), the presence of HIV-1 co-infection can complicate the diagnosis of tuberculosis (TB), with atypical radiographic findings, reduced sensitivity of diagnostic tools [1], and TB often manifesting in extrapulmonary sites which are difficult to access without invasive procedures [2]. In South Africa, TB-HIV coinfection rates are high, and development of tuberculosis in the spine (STB) is one of the most common EPTB sites in PLWH.[3–6] Mycobacterium tuberculosis (Mtb) infection […]
BMJ Open
10. november 2025
[…] To determine the prevalence and factors associated with the uptake of HIV self-testing (HIVST) among adolescent girls and young women (AGYW) attending middle learning institutions in Dodoma City, Tanzania, in 2024. Design: A cross-sectional study design was employed. Setting The study was conducted in five randomly selected colleges in Dodoma City, Tanzania. Participants A total of 771 female students aged 15–24 years who provided informed consent were enrolled. Students who declined […]
Journal of Medical Virology
8. november 2025
Journal of Medical Virology, Volume 97, Issue 11, November 2025.
Clinical Microbiology and Infection
8. november 2025
[…] with Human immunodeficiency virus (HIV) have traditionally been excluded from organ transplantation, as they were considered high risk recipients. Early concerns centered on the perceived ethical and clinical implications of allocating a scarce resource to a population with limited life expectancy at that time, and on fears that post-transplant immunosuppression could accelerate disease progression. These reservations were further amplified by the social and medical stigma and marginalization […]
International Journal of Infectious Diseases
7. november 2025
[…] mycobacteria (NTM) are environmental bacteria [1], and the incidence of NTM disease has increased globally [2–4]. Although the lungs are the primary site of NTM infection [5], NTM can also cause extrapulmonary infections involving the skin, soft tissues, musculoskeletal system, lymph nodes, and other organs [6–8]. Extrapulmonary NTM disease occurs most frequently in immunocompromised patients and was first reported in the 1980s as disseminated Mycobacterium avium complex (MAC) infection in […]
International Journal of Infectious Diseases
7. november 2025
[…] with HIV (PWH) are a clinically vulnerable population for severe COVID-19 [1]. With the emergence of SARS-CoV-2 Omicron sublineages, particularly after the XBB.1.5 variant started to circulate, vaccine updates became necessary due to enhanced immune escape [2]. In December 2023, the Italian Ministry of Health recommended either Nuvaxovid XBB.1.5 (a protein-based vaccine) or Pfizer-BioNTech's monovalent mRNA XBB.1.5 vaccine as autumn/winter boosters, also for PWH [3]. Despite the elevated risk faced […]
BMJ Open
5. november 2025
[…] Saskatchewan is facing a public health crisis driven by high rates of HIV, syphilis and hepatitis C virus (HCV) infections, particularly among people who use drugs. Injection drug use is a major contributor to these syndemic infections, exacerbated by structural barriers such as stigma, poverty and limited culturally safe healthcare. Innovative, community-informed approaches are urgently needed to improve prevention, testing and linkage to care. Methods and analysis This study will implement a […]
BMJ Open
4. november 2025
[…] Current prediction models for disease progression to AIDS in people living with HIV primarily rely on traditional statistical methods. This study aimed to develop and compare four machine learning models and to create a clinically applicable nomogram for identifying risk factors associated with AIDS progression. Design A retrospective cohort study conducted from January 2013 to December 2022. Setting Yining City, Xinjiang, China. Participants Newly diagnosed HIV-infected patients (aged 18–60 […]
International Journal of Infectious Diseases
4. november 2025
[…] read the manuscript describing the retrospective case-control study by Katzschner et al. [1] and their call for renewed attention to HIV-associated disseminated non-tuberculous mycobacterial disease (dNTMd) with great interest. The authors stated that specific contribution of dNTMd to delayed CD4-cell restoration remains understudied; however, they did not cite two studies that outlined this issue before. Lazaro et al. did a study within the ANRS Co3 Aquitaine Cohort, a prospective cohort of people with […]
International Journal of Infectious Diseases
1. november 2025
In 2023, Canada experienced a 35.2% overall increase in new HIV diagnoses compared to 2022, with a total of 2,434 cases reported [1]. Gay, bisexual, and other men who have sex with men (gbMSM) continue to bear a disproportionately high burden of new HIV infections. In 2022, 38.4% of all new infections were among gbMSM [2]. Transgender women (TGW) are another population at elevated risk for HIV and are recognized as a priority group for HIV prevention efforts [3].
Lancet
31. oktober 2025
[…] interconnectedness of the global HIV and sexually transmitted infection (STI) epidemics necessitates integrated strategies to address both. This Series paper highlights the biological link between HIV and STIs, and describes the successful progress in HIV response versus STI response over the past decades. The concept of undetectable=untransmissible (U=U) in HIV treatment has revolutionised HIV prevention by reducing stigma and promoting early treatment. In line with this approach, we discuss the role […]
Journal of Acquired Immune Deficiency Syndromes
30. oktober 2025
[…] determinants of health (SDOH) of people with HIV (PWH) with SUD and reduce HIV transmission risk. We describe access to SUS at HIV care facilities by urbanicity. Methods: We analyzed Medical Monitoring Project (MMP) 2021 data from 514 HIV care facilities and linked these data to MMP respondent data from 2019. We calculated weighted percentages of facility and patient characteristics by urbanicity of HIV care site: counties of ≥1,000,000 people (large metro); 250,000–1,000,000 people (medium metro); […]
Journal of Infectious Diseases
30. oktober 2025
[…] gastrointestinal (GI) tract is a major reservoir of HIV and home to the body’s most diverse microbiome. However, the role of gut bacteriome in modulating local HIV persistence remains uninvestigated.MethodsLeveraging rapid autopsy samples (n=113) from 24 people with HIV (PWH) in the Last Gift cohort, we performed 16S rRNA sequencing and quantified total HIV DNA and msTat/Rev RNA (ddPCR) across five GI segments (duodenum, jejunum, ileum, colon, rectum). Associations between relative […]
AIDS
30. oktober 2025
[…] The 2025 US National HIV/AIDS Strategy identifies intimate partner violence (IPV) as a key social determinant in the HIV response. Women living with HIV (WLHIV) face heightened IPV risk, especially during pregnancy. We evaluated the associations between reproductive stage, structural risk factors and past-year IPV among WLHIV in the US. Design: We conducted a cross-sectional analysis using 2022–2025 baseline survey data from the HOPE prospective cohort of WLHIV across 14 sites in 9 US […]
AIDS
30. oktober 2025
[…] demonstrated safety and efficacy in a variety of malignancies, including cancers affecting patients with human immunodeficiency virus (PWH). However, there is limited data directly comparing efficacy of ICI use between cancer patients with versus without HIV. Methods: Real-world retrospective data were used to compare clinical outcomes between 24 PWH and cancer 24 matched cancer patients without HIV, all treated with ICI therapy. Results: Adverse event rates did not differ by HIV status. Overall response […]
AIDS
30. oktober 2025
[…] Estimating undiagnosed HIV prevalence facilitates planning epidemic responses, and monitoring progress towards UNAIDS and national targets. We undertook a systematic review to identify models used to estimate undiagnosed HIV prevalence in overall populations in high income low HIV prevalence countries and territories to inform model selection in New Zealand (NZ). Methods: We searched Medline, EMBASE, Web of Science, CINAHL and Cochrane Database of Systematic Reviews to 5th March 2025. Two […]
PLoS One Infectious Diseases
30. oktober 2025
[…] Kristina M. Kokorelias, Soo Chan Carusone, Christine Sheppard, Andrew D. Eaton, Cynthia Chui, Dean Valentine, Michael Kirk, Luxey Sirisegaram Background The growing population of older adults living with HIV presents unique challenges for long-term care facilities, which are increasingly tasked with supporting residents who require both HIV-specific and geriatric care. Despite advances in HIV treatment that have extended life expectancy, the needs of these individuals in long-term care remain […]
BMC Infectious Diseases
29. oktober 2025
Aktuelle smitsomme sygdomme [+20]
Der er mere end 20 resultater, måske du vil se flere resultater her?
Medscape Infectious Diseases
28. oktober 2025
Patients with multidrug resistant HIV infection who switch to a single tablet of bictegravir/emtricitabine/tenofovir alafenamide maintain viral suppression and tolerate the regimen well. Medscape Medical News
Medscape Infectious Diseases
27. oktober 2025
Swiss study shows 60% of migrant HIV diagnoses are made post-arrival, challenging assumptions about when infections actually occur. Medscape Medical News
Medscape Infectious Diseases
23. oktober 2025
HBcAb-positive, HBsAg-negative people with HIV can safely switch from tenofovir-containing ART without clinically significant HBV reactivation. Medscape Medical News
Medscape Infectious Diseases
23. oktober 2025
The drug can be produced for as little as $25 per person annually, but even at $2000 per person, it can reduce new US infections almost entirely, a researcher says. Medscape Medical News
Medscape Infectious Diseases
23. oktober 2025
A study of an urban US population reports a sharp decline in dermatologic disease in people with newly diagnosed HIV and identifies risk for vulnerable groups. Medscape Medical News
Medscape Infectious Diseases
22. oktober 2025
Among patients with late diagnosed HIV infection, the choice of a two- or three-drug regimen is not associated with 48 week viral suppression or treatment discontinuation. Medscape Medical News
Medscape Infectious Diseases
21. oktober 2025
Stigma, late diagnosis, and patchy access keep Europe from its HIV milestones. What will it take to close the gap? Medscape Medical News
Medscape Infectious Diseases
18. oktober 2025
New guidance also spans prevention, screening, vaccines, mental health, and HIV-2, and is designed to help clinics manage older patients with complex needs. Medscape Medical News
Medscape Infectious Diseases
18. oktober 2025
NICE has recommended cabotegravir, the UK’s first long-acting injectable HIV prevention drug, expanding access for people unable to take daily tablets. Medscape News UK
Medscape Infectious Diseases
16. oktober 2025
More than 40 years after the first AIDS cases, new long-acting drugs and antibody-based therapies are reviving hopes that HIV infection could one day be curable. Medscape Medical News
Medscape Infectious Diseases
15. oktober 2025
The 21-valent pneumococcal conjugate vaccine V116 is well tolerated in adults living with HIV and induces immunity to all 21 serotypes, with responses similar to those of the current standard regimen. Medscape Medical News
Medscape Infectious Diseases
9. oktober 2025
Early initiation of antiretroviral therapy does not provide significant cardiovascular benefits compared with delayed initiation in people living with HIV who have high CD4+ counts. Medscape Medical News
Medscape Infectious Diseases
9. oktober 2025
New UKHSA data show a continued drop in HIV diagnoses and deaths across the UK, but experts warn that inequalities and gaps in testing remain. Medscape News UK
Medscape Infectious Diseases
7. oktober 2025
Pregnant women with HIV infection receiving oral rilpivirine antiretroviral regimens do not have higher rates of adverse pregnancy or birth outcomes than those on nonrilpivirine regimens. Medscape Medical News
Eurosurveillance latest updates
3. oktober 2025
[…] December 2024 and August 2025, two Italian HIV/STI clinics offered long-acting injectable cabotegravir (CAB-LA) for HIV prevention in 265 individuals, representing the first European real-world implementation. Participants were prioritised based on vulnerabilities compromising oral pre-exposure prophylaxis (PrEP), such as poor adherence, comorbidities and behavioural barriers. Adherence to injections exceeded 95%, tolerability was favourable and only 1.5% discontinued for drug-related reasons. […]
Medscape Infectious Diseases
1. oktober 2025
Lamivudine/dolutegravir is effective as first-line therapy for HIV infection, with low rates of treatment failure. Medscape Medical News
Medscape Infectious Diseases
26. september 2025
New NIH-funded research will explore broadly applicable HIV cures based on three success stories. Medscape Medical News
Medscape Infectious Diseases
25. september 2025
Indian drugmakers Dr Reddy\'s Laboratories and Hetero Labs said on Wednesday that they will sell generic versions of a new and highly effective HIV prevention drug for... Reuters Health Information
Morbidity and Mortality Weekly Report (MMWR)
19. september 2025
This report describes a clinical recommendation to use injectable lenacapavir as an HIV preexposure prophylaxis.
Eurosurveillance latest updates
12. september 2025
[…] global goal to end the AIDS epidemic cannot be achieved without estimates of incidence and undiagnosed infection. AIMWe aimed to estimate the timing of HIV transmission events and the number of people unaware of their diagnosis in Scotland, by mode of acquisition and migrant status. METHODSSurveillance data from Scotland’s national HIV diagnosis database (1981–2022) linked to death and migration data was entered into the HIV Platform tool of the European Centre for Disease Prevention and […]